JGM Segalla

SOLTI-0701: A Multinational Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo When Administered in Combination with Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer (BC).

José Baselga, H. Roché, F. Costa et al. · Cancer Research · 2009 · 52 citations

Breast Oncology, Cancer Management, Advanced Bc +17

Clinical Characteristics and Outcome of Treatment of Brazilian Women with Breast Cancer Treated at Public and Private Institutions – The AMAZONE Project of the Brazilian Breast Cancer Study Group (GBECAM).

Sérgio D. Simon, José Bines, C.H. Barrios et al. · Cancer Research · 2009 · 32 citations

Breast Oncology, Cancer Management, Epidemiology Of Cancer +18

3LBA SOLTI-0701: A double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in patients (pts) with locally advanced (adv) or metastatic (met) breast cancer (BC)

José Baselga, JGM Segalla, Henri Roché et al. · European Journal of Cancer Supplements · 2009 · 25 citations

Breast Oncology, Oncology, Phase 2B +7

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

Miguel Martín, CH Barrios, Laura Torrecillas et al. · Cancer Research · 2019 · 10 citations

Surgical Oncology, Breast Oncology, Adjuvant Capecitabine +18